Cargando…

Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis – a multicenter trial

The development of antifilarial antibody responses is a characteristic feature of infection with filarial parasites. It should be possible to exploit this fact to develop tools to monitor the progress of the global program to eliminate lymphatic filariasis (LF); however, assays based on parasite ext...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lammie, Patrick J, Weil, Gary, Noordin, Rahmah, Kaliraj, Perumal, Steel, Cathy, Goodman, David, Lakshmikanthan, Vijaya B, Ottesen, Eric
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC519021/ https://www.ncbi.nlm.nih.gov/pubmed/15347425 http://dx.doi.org/10.1186/1475-2883-3-9

Ejemplares similares

Pan LF-ELISA using BmR1 and BmSXP recombinant antigens for detection of lymphatic filariasis
por: Abdul Rahman, Rohana, et al.
Publicado: (2007)

Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis
por: Pantelias, Anastasia, et al.
Publicado: (2022)

Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation
por: Chu, Brian K., et al.
Publicado: (2013)

Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success
por: Ichimori, Kazuyo, et al.
Publicado: (2014)

Elucidation of immunological response and its regulatory network by P-TUFT-ALT-2: a promising fusion protein vaccine for human lymphatic filariasis
por: Paul, Rajkumar, et al.
Publicado: (2018)

Diagnostics to support elimination of lymphatic filariasis—Development of two target product profiles
por: Won, Kimberly Y., et al.
Publicado: (2021)

Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame
por: Lau, Colleen L., et al.
Publicado: (2016)

Comparison of IgG4 assays using whole parasite extract and BmR1 recombinant antigen in determining antibody prevalence in brugian filariasis
por: Noordin, Rahmah, et al.
Publicado: (2004)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

Recombinant antigens used as diagnostic tools for lymphatic filariasis
por: Pastor, André Filipe, et al.
Publicado: (2021)

Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis
por: Lammie, Patrick J, et al.
Publicado: (2020)

Application of the Filariasis CELISA Antifilarial IgG(4) Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific
por: Joseph, Hayley, et al.
Publicado: (2011)

Surveillance and Vector Control of Lymphatic Filariasis in the Republic of Korea
por: Cho, Shin Hyeong, et al.
Publicado: (2012)

Multicentre evaluations of two new rapid IgG4 tests (WB rapid and panLF rapid) for detection of lymphatic filariasis
por: Noordin, Rahmah, et al.
Publicado: (2007)

Elimination of lymphatic filariasis as a public health problem from the Cook Islands
por: Ave, Charlie, et al.
Publicado: (2018)

Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti
por: Lammie, Patrick J., et al.
Publicado: (2017)

MDA—Lymphatic Filariasis
por: Ichimori, Kazuyo
Publicado: (2014)

Urban lymphatic filariasis
por: Simonsen, Paul E., et al.
Publicado: (2012)

The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years
por: Ottesen, Eric A., et al.
Publicado: (2008)

IgG(4) antibodies to the recombinant filarial antigen Wb-Bhp-1 decrease dramatically following treatment of lymphatic filariasis
por: Greene, Sarah E., et al.
Publicado: (2023)

Evaluation of the recombinant antigens Wb14 and WbT for the capture antibody diagnosis of lymphatic filariasis
por: Pastor, André Filipe, et al.
Publicado: (2018)

Secondary Mapping of Lymphatic Filariasis in Haiti-Definition of Transmission Foci in Low-Prevalence Settings
por: Drexler, Naomi, et al.
Publicado: (2012)

Geospatial modelling of lymphatic filariasis and malaria co-endemicity in Nigeria
por: Eneanya, Obiora A, et al.
Publicado: (2023)

Use of Antibody Tools to Provide Serologic Evidence of Elimination of Lymphatic Filariasis in The Gambia
por: Won, Kimberly Y., et al.
Publicado: (2018)

Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis
por: Harris, Julie R., et al.
Publicado: (2017)

Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa
por: Won, Kimberly Y., et al.
Publicado: (2018)

Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875–2000)
por: Ottesen, Eric A, et al.
Publicado: (2020)

Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania
por: Martin, Diana, et al.
Publicado: (2018)

Mapping of lymphatic filariasis in Nepal
por: Sherchand, Jeevan B, et al.
Publicado: (2003)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

Progress and Impact of 13 Years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease
por: Ramaiah, K. D., et al.
Publicado: (2014)

Eliminating Lymphatic Filariasis, Onchocerciasis, and Schistosomiasis from the Americas: Breaking a Historical Legacy of Slavery
por: Lammie, Patrick J., et al.
Publicado: (2007)

The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs
por: Mathew, Christopher G, et al.
Publicado: (2020)

Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination
por: Michael, Edwin, et al.
Publicado: (2018)

Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China
por: Fang, Yuan, et al.
Publicado: (2019)

Socio-Environmental Risk Indicator: A Possible Tool for Surveillance of Lymphatic Filariasis
por: Xavier, Amanda, et al.
Publicado: (2023)

The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000–2014)
por: Turner, Hugo C., et al.
Publicado: (2016)

A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000–2020)
por: Turner, Hugo C., et al.
Publicado: (2022)

Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
por: Lau, Colleen L., et al.
Publicado: (2014)

Risk factors for lymphatic filariasis in two villages of the Democratic Republic of the Congo
por: Chesnais, Cédric B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cljljn5b5lc9odk91fhmrt1lo3